Back to Search
Start Over
Engaging with the private healthcare sector for the control of tuberculosis in India: cost and cost-effectiveness
- Source :
- BMJ Global Health, Vol 6, Iss 10 (2021), BMJ Global Health
- Publication Year :
- 2021
- Publisher :
- BMJ, 2021.
-
Abstract
- BackgroundThe control of tuberculosis (TB) in India is complicated by the presence of a large, disorganised private sector where most patients first seek care. Following pilots in Mumbai and Patna (two major cities in India), an initiative known as the ‘Public–Private Interface Agency’ (PPIA) is now being expanded across the country. We aimed to estimate the cost-effectiveness of scaling up PPIA operations, in line with India’s National Strategic Plan for TB control.MethodsFocusing on Mumbai and Patna, we collected cost data from implementing organisations in both cities and combined this data with models of TB transmission dynamics. Estimating the cost per disability adjusted life years (DALY) averted between 2014 (the start of PPIA scale-up) and 2025, we assessed cost-effectiveness using two willingness-to-pay approaches: a WHO-CHOICE threshold based on per-capita economic productivity, and a more stringent threshold incorporating opportunity costs in the health system.FindingsA PPIA scaled up to ultimately reach 50% of privately treated TB patients in Mumbai and Patna would cost, respectively, US$228 (95% uncertainty interval (UI): 159 to 320) per DALY averted and US$564 (95% uncertainty interval (UI): 409 to 775) per DALY averted. In Mumbai, the PPIA would be cost-effective relative to all thresholds considered. In Patna, if focusing on adherence support, rather than on improved diagnosis, the PPIA would be cost-effective relative to all thresholds considered. These differences between sites arise from variations in the burden of drug resistance: among the services of a PPIA, improved diagnosis (including rapid tests with genotypic drug sensitivity testing) has greatest value in settings such as Mumbai, with a high burden of drug-resistant TB.ConclusionsTo accelerate decline in TB incidence, it is critical first to engage effectively with the private sector in India. Mechanisms such as the PPIA offer cost-effective ways of doing so, particularly when tailored to local settings.
- Subjects :
- Strategic planning
Medicine (General)
Tuberculosis in India
Health economics
Opportunity cost
Cost effectiveness
Cost-Benefit Analysis
Health Policy
Public Health, Environmental and Occupational Health
Health Care Sector
India
Infectious and parasitic diseases
RC109-216
Private sector
R5-920
tuberculosis
Environmental health
Humans
health economics
Private Sector
Private healthcare
Business
Original Research
Cost database
Subjects
Details
- ISSN :
- 20597908
- Volume :
- 6
- Database :
- OpenAIRE
- Journal :
- BMJ Global Health
- Accession number :
- edsair.doi.dedup.....6e683106ccfc2cee9104ea0ca5bfd9dd
- Full Text :
- https://doi.org/10.1136/bmjgh-2021-006114